Successful Use of Recombinant Factor VIIa (NovoSeven) During Cardiac Surgery in a Pediatric Patient with Glanzmann Thrombasthenia

被引：0
|
作者：
B.T. Yilmaz
B. Alioglu
E. Ozyurek
H.T. Akay
S. Mercan
N. Ozbek
机构：
[1] Baskent University Faculty of Medicine,Department of Pediatrics, Pediatric Hematology Unit
[2] Baskent University Faculty of Medicine,Department of Cardiovascular Surgery
来源：
Pediatric Cardiology | 2005年 / 26卷
关键词：
Recombinant factor VIIa; Cardiopulmonary bypass; Cardiac surgery; Glanzmann thrombasthenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Glanzmann thrombasthenia is a rare, hereditary, congenital disorder of platelet function characterized by inappropriate bleeding that is difficult to control. Recombinant activated factor VII (rFVIIa) is a new treatment that is used to stop bleeding and provide surgical support for these patients. This report describes the use of rFVIIa to prevent serious bleeding during and after open-heart surgery in a child with Glanzmann thrombasthenia.
引用
收藏
页码：843 / 845
页数：2
相关论文
共 50 条
  • [21] Perioperative Management of a Pediatric Patient with Glanzmann's Thrombasthenia during Adenoidectomy
    Duman, Erdem Nail
    Saylan, Sedat
    Cekic, Bahanur
    REVISTA BRASILEIRA DE ANESTESIOLOGIA, 2012, 62 (04): : 548 - 553
  • [22] The safety of recombinant factor VIIa in cardiac surgery
    Mitra, B.
    Phillips, L.
    Cameron, P. A.
    Billah, B.
    Reid, C.
    ANAESTHESIA AND INTENSIVE CARE, 2010, 38 (04) : 671 - 677
  • [23] The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy
    Erduran, Erol
    Aksoy, Ayse
    Zaman, Dilek
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (03) : 215 - 217
  • [24] Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven)
    Zülfikar, B
    Kayiran, SM
    BLOOD COAGULATION & FIBRINOLYSIS, 2004, 15 (03) : 261 - 263
  • [25] American experience with home use of NovoSeven(R): Recombinant factor VIIa in hemophiliacs with inhibitors
    Shapiro, AD
    HAEMOSTASIS, 1996, 26 : 143 - 149
  • [26] Use of recombinant factor VIIa as a rescue therapy for excessive bleeding after cardiac surgery
    Senay, Sahin
    Karabulut, Hasan
    Toraman, Fevzi
    Ratip, Siret
    Alhan, Cem
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 18 (04): : 324 - 326
  • [27] The use of recombinant factor VIIa for severe intractable bleeding during spine surgery
    Kaw, LL
    Coimbra, R
    Potenza, BM
    Garfin, SR
    Hoyt, DB
    SPINE, 2004, 29 (12) : 1384 - 1387
  • [28] Successful Use of Hematopoietic Stem Cell Transplantation for 2 Pediatric Cases of Glanzmann Thrombasthenia and Review of the Literature
    Friend, Brian D.
    Roach, Gavin D.
    Kempert, Pamela H.
    Moore, Theodore B.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (06) : E521 - E526
  • [29] Use of activated recombinant factor VII (NovoSeven) - During neurosurgery
    Karadimov, D
    Binev, K
    Nachkov, Y
    Platikanov, V
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2003, 15 (04) : 330 - 332
  • [30] Successful treatment of intractable hemothorax with recombinant factor VIIa in a nonhemophilic patient
    Wei, Yu-Feng
    Ho, Chao-Chi
    Lin, Ming-Tzer
    Yuan, Ang
    Yu, Chong-Jen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2006, 105 (09) : 765 - 769
12345